Most attempts to create therapeutic cancer vaccines are based on custom-made approaches that use a patient’s own tumor cells to generate a strong immune response against cancer.
A new study from the University of Pittsburgh Cancer Institute suggests that a commonly used herbal supplement, triphala, has cancer-fighting properties that prevent or slow the growth of pancreatic cancer tumors implanted in mice.
Chemicals in cruciferous vegetables, such as broccoli, watercress, cabbage and cauliflower, appear to not only stop human prostate cancer cells from growing in mice but also may cut off the formation of blood vessels that “feed” tumors, says a University of Pittsburgh Cancer Institute study.
A cancer-suppressing gene has been successfully delivered into the tumors of stage four lung cancer patients via an intravenously administered lipid nanoparticle in a phase I clinical trial at the University of Texas M. D. Anderson Cancer Center. The gene, FUS1, also was found to be active in the metastatic nonsmall cell lung cancer tumors.
Johns Hopkins University researchers have cured malaria-infected mice with single shots of a new series of potent, long lasting synthetic drugs modeled on an ancient Chinese herbal folk remedy.
The controversial drug dipyrone can treat acute headaches, but patients should be warned of the risk of potentially serious blood disorders (or “dyscrasias”), concluded a Cochrane Review team.
Legislation that requires people to wear bicycle helmets appears to increase use and decreases injury rates, according to the results of a Cochrane Review. Cycling is a popular pastime and a mode of transport for children, but it also leads to many injuries that are frequently sufficiently severe to require hospitalisation. This is a global problem, and particularly effects low-income countries where the proportion of cycle-users is high.
Five minutes of straight talk between doctors and problem drinkers could help reduce the toll of alcohol-related injuries, violence and accidents. Doctors have long questioned whether a single, short discussion with patients about their drinking could have significant effects on alcohol-related problems, despite dozens of studies supporting such “brief interventions.” However, a new review should lay those doubts to rest.
The American Association for Cancer Research, together with the Food and Drug Administration and National Cancer Institute, today announces the formation of the AACR-FDA-NCI Cancer Biomarkers Collaborative to facilitate the use of validated biomarkers in clinical trials and ultimately in evidence-based oncology and cancer medicine.
“ACP strongly believes in the goal of widespread adoption and use of health information technology to improve quality of care,” Michael H. Zaroukian, M.D., Ph.D., F.A.C.P., told the National Committee on Vital and Health Statistics subcommittee on Privacy and Confidentiality today at their hearing on “Consumer Controls for Sensitive Health Records.”